No article text was recorded for this version.
efflux-mediated drug resistance
Version 2 of 268 papers87 conceptsfrozen 2026-10-04
Papers in this version
- Blog: RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.
- Blog: IBD: Pathogenesis
- Blog: The Battlefield of Chemotherapy in Pediatric Cancers
- Blog: The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- Blog: Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
- Blog: Expression patterns of MRP2 in circulating tumor cells of breast cancer: a single-institution study
- Blog: Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis
- Blog: Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
- Blog: Luteolin increases susceptibility to macrolides by inhibiting MsrA efflux pump in Trueperella pyogenes
- Blog: Overcome cancer drug resistance by targeting epigenetic modifications of centrosome
- Blog: Yeast Double Transporter Gene Deletion Library for Identification of Xenobiotic Carriers in Low or High Throughput
- Blog: Utidelone inhibits growth of colorectal cancer cells through ROS/JNK signaling pathway
- Blog: Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells
- Blog: Expression Profiling of ABC Transporters in a Drug-Resistant Breast Cancer Cell Line Using AmpArray
- Blog: The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis
- Blog: Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
- Blog: PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer
- Blog: Antitumor components and mechanisms of Zanthoxylum bungeanum Maxim with medicine and food homology
- Blog: Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
- Blog: siRNA-Mediated Silencing of Antifungal Resistance Genes: A Research Protocol
- Blog: Nanoformulation-based drug delivery systems for the treatment of gastric cancer: recent developments and future prospects
- Blog: Computational analysis and predictive modeling of polymorph descriptors
- Blog: Remodeling tumor microenvironment with natural products to overcome drug resistance
- Blog: Author Correction: pH-sensitive micelles for the intracellular co-delivery of curcumin and Pluronic L61 unimers for synergistic reversal effect of multidrug resistance
- Blog: Overcoming Tumor Drug Resistance with High‐Affinity Taxanes: A SAR Study of C2‐Modified 7‐Acyl‐10‐Deacetyl Cephalomannines
- Blog: Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
- Blog: Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria
- Blog: Molecular biology of cantharidin in cancer cells
- Blog: Prostate cancer stem cells: an updated mini-review
- Blog: Study of Structure and Permeability Relationship of Flavonoids in Caco-2 Cells
- Blog: Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
- Blog: The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
- Blog: Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010
- Blog: A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro
- Blog: [Efficacy and safety of PEMD regimen in newly diagnosed early-stage non-upper respiratory digestive tract or advanced extranodal natural killer/T-cell lymphoma].
- Blog: In Vitro Metabolism, Permeability, and Efflux of Bazedoxifene in Humans
- Blog: Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets
- Blog: CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
- Blog: ADMET Evaluation in Drug Discovery. 13. Development of<i>in Silico</i>Prediction Models for P-Glycoprotein Substrates
- Blog: Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer
- Blog: Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
- Blog: Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells
- Blog: Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy
- Blog: Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
- Blog: Natural Melanin-Based Nanoparticles With Combined Chemo/Photothermal/Photodynamic Effect Induce Immunogenic Cell Death (ICD) on Tumor
- Blog: ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning
- Blog: Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells
- Blog: Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: Implications of genistein metabolism in the rat
- Blog: Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression
- Blog: Emerging magic bullet: subcellular organelle-targeted cancer therapy
- Blog: Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
- Blog: Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression
- Blog: Environmentally responsive dual-targeting nanotheranostics for overcoming cancer multidrug resistance
- Blog: Artificial cell vesicle-mediated delivery of Catharanthus roseus (L.) G. Don-derived vinca alkaloids for enhanced antitumor efficacy
- Blog: The Mechanism of Tigecycline Resistance in Acinetobacter baumannii under Sub-Minimal Inhibitory Concentrations of Tigecycline
- Blog: Genomic characterisation of the metal tolerance protein gene family and elucidation of functional role in heavy metal tolerance and accumulation in Coptis chinensis
- Blog: Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment
- Blog: Transcriptome-Based Identification and Characterization of Genes Associated with Resistance to Beta-Cypermethrin in Rhopalosiphum padi (Hemiptera: Aphididae)
- Blog: From fighting depression to conquering tumors: a novel tricyclic thiazepine compound as a tubulin polymerization inhibitor
- Blog: Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation
Showing 60 of 68 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_efflux_mediated_drug_resistance_0fd9e84d,
title = {efflux-mediated drug resistance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/efflux-mediated-drug-resistance/rdr_0fd9e84d157c46c0a71245a57af4cb6c},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 2, frozen text):
@misc{lacuna_efflux_mediated_drug_resistance_0fd9e84d_v2,
title = {efflux-mediated drug resistance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/efflux-mediated-drug-resistance/rdr_0fd9e84d157c46c0a71245a57af4cb6c/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-20},
}